Skip to main content
Fig. 10 | BMC Molecular and Cell Biology

Fig. 10

From: Polyvalent therapeutic vaccine for type 2 diabetes mellitus: Immunoinformatics approach to study co-stimulation of cytokines and GLUT1 receptors

Fig. 10

Activation of T-cells by peptide-MHC complex and cytokines production. In silico binding affinity analysis of T2DM polyvalent vaccine model with MHC-class molecule indicates optimum binding pattern (− 15.33 kcal/mol) a Molecular docking visual of polyvalent model with MHC class-I molecule b Potential interaction of polyvalent vaccine with amino acid residues of MHC class-I

Back to article page